News - Page 2

After receiving a checkered regulatory scorecard in 2024, Aurobindo’s sterile injectables and oncology unit is back in the FDA’s crosshairs.

Canada-based Eurofins CDMO Alphora boosted its development and production to meet growing demand for both non-potent and high-potency APIs.

Arguing that the Defense Department might have misread the evidence and inflicted harm on the company, a federal judge has thrown WuXi AppTec a lifeline as the research and manufacturing services juggernaut

The FDA has denied ITM Isotopes Technologies’ lead pipeline candidate for a rare group of tumors due to qualms over the drug’s manufacturing.

Bristol Myers Squibb has laid out plans for a $2.3 billion manufacturing facility in Houston, set for completion in 2030. The plant will cover 600,000 square feet and employ nearly 500 people.

Fresenius Kabi voluntarily recalled one lot of morphine sulfate injection due to a labeling mix-up with prefilled syringes of dilaudid that could trigger an overdose resulting in severe respiratory distress or death.

Fujifilm Biotechnologies passed the leadership reins to Maja Pedersen, adding president to her current role as COO while former Chief Executive Lars Petersen transitions to a strategic advisor position.

Gerresheimer, a Germany-based packaging company that specializes in drug delivery systems and glass and plastic packaging, sold two of its units to the private equity group Apax Partners in a deal valued

Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies plan to invest $750 million to increase production of Lilly’s KwikPen injectable device for its diabetes and obesity

Baxter issued a voluntary recall of one lot of cefazolin in dextrose injection after a report that cardboard was found in an IV infusion bag.